全文获取类型
收费全文 | 48998篇 |
免费 | 3188篇 |
国内免费 | 188篇 |
专业分类
耳鼻咽喉 | 525篇 |
儿科学 | 1231篇 |
妇产科学 | 858篇 |
基础医学 | 6401篇 |
口腔科学 | 1252篇 |
临床医学 | 4765篇 |
内科学 | 9990篇 |
皮肤病学 | 726篇 |
神经病学 | 4780篇 |
特种医学 | 2551篇 |
外国民族医学 | 6篇 |
外科学 | 7213篇 |
综合类 | 592篇 |
一般理论 | 40篇 |
预防医学 | 4018篇 |
眼科学 | 1199篇 |
药学 | 2929篇 |
中国医学 | 70篇 |
肿瘤学 | 3228篇 |
出版年
2023年 | 207篇 |
2022年 | 348篇 |
2021年 | 807篇 |
2020年 | 612篇 |
2019年 | 811篇 |
2018年 | 951篇 |
2017年 | 773篇 |
2016年 | 914篇 |
2015年 | 1051篇 |
2014年 | 1470篇 |
2013年 | 2045篇 |
2012年 | 3101篇 |
2011年 | 3289篇 |
2010年 | 1868篇 |
2009年 | 1708篇 |
2008年 | 3062篇 |
2007年 | 3155篇 |
2006年 | 3109篇 |
2005年 | 3040篇 |
2004年 | 2847篇 |
2003年 | 2762篇 |
2002年 | 2661篇 |
2001年 | 616篇 |
2000年 | 570篇 |
1999年 | 638篇 |
1998年 | 603篇 |
1997年 | 468篇 |
1996年 | 423篇 |
1995年 | 405篇 |
1994年 | 323篇 |
1993年 | 292篇 |
1992年 | 371篇 |
1991年 | 338篇 |
1990年 | 308篇 |
1989年 | 325篇 |
1988年 | 292篇 |
1987年 | 308篇 |
1986年 | 279篇 |
1985年 | 300篇 |
1984年 | 305篇 |
1983年 | 292篇 |
1982年 | 319篇 |
1981年 | 297篇 |
1980年 | 263篇 |
1979年 | 225篇 |
1978年 | 234篇 |
1977年 | 195篇 |
1976年 | 168篇 |
1975年 | 177篇 |
1974年 | 183篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
5.
Oral Everolimus for Treatment of a Giant Left Ventricular Rhabdomyoma in a Neonate—Rapid Tumor Regression Documented by Real Time 3D Echocardiography 下载免费PDF全文
Robert Wagner M.D. Ph.D. Frank Thomas Riede M.D. Hiroshi Seki M.D. Frauke Hornemann M.D. Steffen Syrbe M.D. Ingo Daehnert M.D. Ph.D. Michael Weidenbach M.D. Ph.D. 《Echocardiography (Mount Kisco, N.Y.)》2015,32(12):1876-1879
The presented case reports on successful treatment with everolimus in a neonate with left ventricular giant rhabdomyoma. The authors used a different dosage regime compared to literature and documented rapid tumor regression by 3D echocardiography. 相似文献
6.
7.
Genomes of some parasites contain dozens of alternative and highly diverged surface antigens, of which only a single one is expressed in any cell. Individual cells occasionally change expression of their surface antigen, allowing them to escape immune surveillance. These switches appear to occur in a partly random way, creating a diverse set of antigenic variants. In spite of this diversity, the parasitemia develops as a series of outbreaks, in which each outbreak is dominated by relatively few antigenic types. Host-specific immunity eventually clears the dominant antigenic types, and a new outbreak follows from antigenic types that have apparently been present all along at low frequency. This pattern of sequential dominance by different antigenic types remains unexplained. We review the five most prominent theories, which have developed mainly from studies of the protozoans Trypanosoma and Plasmodium, and the bacterial spirochete Borrelia. The most promising theories depend on some combination of mechanisms to create favored connectivity pathways through the matrix of transitions between variants. Favored pathways may arise from biased switches at the molecular level of gene expression or from biases imposed by immune selection. We illustrate the concept of connectivity pathways by reanalysis of data on transitions between variants from Borrelia hermsii. 相似文献
8.
9.
10.
There are an estimated 200 million users of an illicit drug in the world today. In addition, an estimated 40 million people are infected with the human immunodeficiency virus (HIV) and an estimated 180 million people are infected with the hepatitis C virus (HCV). Both the use of an illicit drug and the co-occurrence of infections are associated with a multitude of medical and health consequences including hormonal and metabolic disorders. Thus, the National Institute on Drug Abuse (NIDA), a part of the National Institutes of Health (NIH) hosted a workshop on hormonal and metabolic disorders of HIV among substance abusers. A number of clinicians and scientists participated and discussed a wide range of issues concerning hormones, nutrition and metabolic complications in HIV and substance abuse. Their observations and the recommendations they made for future research are presented in these proceedings. The readers are encouraged to contact the NIH staff (JK, FV) for technical guidance and programmatic priorities on the subject and directly contact the individual authors for collaborations. 相似文献